Home › Funds › Frazier Life Sciences Management, L.P. › PVLA
Frazier Life Sciences Management, L.P. position in PVLA
PALVELLA THERAPEUTICS INC NEW COM · Health Care
Frazier Life Sciences Management, L.P. reported holding 882,400 shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM) in its Q2 2026 13F filing — a position valued at US$134.8M, representing 2.94% of its reported portfolio and ranking #10 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed PVLA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Frazier Life Sciences Management, L.P.'s PVLA position evolved
Frazier Life Sciences Management, L.P. first disclosed a stake in PVLA in Q4 2024 at 653,892 shares (US$7.8M). The position peaked in Q2 2026 at 882,400 shares, worth US$134.8M. Across 7 filings, Frazier Life Sciences Management, L.P. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 882,400 shares valued at US$134.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 653.89K | $7.85M | New |
| Q1 2025 | 690.01K | $19.31M | Add |
| Q2 2025 | 722.40K | $16.28M | Add |
| Q3 2025 | 722.40K | $45.29M | Hold |
| Q4 2025 | 722.40K | $75.61M | Hold |
| Q1 2026 | 882.40K | $109.99M | Add |
| Q2 2026 | 882.40K | $134.85M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PVLA and 13F data
PVLA (PALVELLA THERAPEUTICS INC NEW COM) is a Health Care company. 90 other funds we track also report a position in PVLA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$173.5M), First Light Asset Management, LLC (US$118.0M), BVF INC/IL (US$102.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PVLA
- MONTANOVA CAPITAL, LLC 1.14M sh · $173.51M · Q2 2026
- First Light Asset Management, LLC 771.90K sh · $117.96M · Q2 2026
- BVF INC/IL 672.79K sh · $102.82M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 478.83K sh · $73.18M · Q2 2026
- Siren, L.L.C. 257.49K sh · $39.35M · Q2 2026
- EMERALD ADVISERS, LLC 229.49K sh · $35.07M · Q2 2026
- MPM BioImpact LLC 204.03K sh · $31.18M · Q2 2026
- First Turn Management, LLC 156.45K sh · $23.91M · Q2 2026
- Bellevue Group AG 155.00K sh · $23.69M · Q2 2026
- NEXTBio Capital Management LP 89.91K sh · $13.74M · Q2 2026
- Clio Asset Management LLC 86.01K sh · $11.86M · Q3 2026
- Avidity Partners Management LP 70.00K sh · $10.70M · Q2 2026
More on Frazier Life Sciences Management, L.P.
FAQ
How long has Frazier Life Sciences Management, L.P. held PVLA?
Frazier Life Sciences Management, L.P. has disclosed PVLA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Frazier Life Sciences Management, L.P.'s current position in PVLA?
As of Q2 2026, Frazier Life Sciences Management, L.P. holds 882.40K shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM), valued at $134.85M, representing 2.94% of its reported portfolio and ranking #10.
Has Frazier Life Sciences Management, L.P. been buying or selling PVLA?
In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in PVLA. The position peaked in Q2 2026 at 882.40K shares.
Which other funds hold PVLA?
Other major institutional holders of PVLA include MONTANOVA CAPITAL, LLC, First Light Asset Management, LLC, BVF INC/IL, among 90 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.